Medpace adds clinical pharma unit for PhI trials

CRO Medpace is doubling its capacity for Phase I studies at its Cincinnati facility, adding a 96-bed clinical pharmacology unit. The development follows what appears to be a trend among CROs, Outsourcing-Pharma notes, as many large companies are opening in-patient facilities designed to house early-stage trials. Report

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.